Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In: Program and abstracts of the American Diabetes Association (ADA) 68th Sessions, June 6-10, 2008, San Francisco, California
M., Smid, E
This paradigm shift underscores that therapeutic strategies must target the underlying metabolic dysfunction, not just symptomatic pain relief
Earlier GLP-1 drugs, such as exenatide and liraglutide, produced modest weight loss of 510% of body weight
US$ 21.13
US$ 23.28
US$ 26.45
US$ 21.71
US$ 25.32
US$ 25.30
US$ 20.59
US$ 25.92
US$ 21.52
US$ 25.14
US$ 29.25
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
